Abstract
Background
Little is known about parental awareness of multisystem inflammatory syndrome in children (MIS-C), a rare but severe sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Methods
Via a nationally representative, cross-sectional survey of US parents conducted via Ipsos KnowledgePanel from October to November 2021, we used bivariate and multivariable analyses to describe and identify demographic variables associated with parental knowledge of and attitudes toward MIS-C and to examine associations with perceived coronavirus disease 2019 (COVID-19) severity and susceptibility.
Results
Response rate was 64.2% (3230/5034). Thirty-two percent of respondents had heard of MIS-C. After adjustment, higher educational level (compared to high school degree; some college: odds ratio [OR], 2.00 [95% confidence interval {CI}, 1.44–2.77]; bachelor's degree or higher: OR, 3.14 [95% CI, 2.26–4.35]), being a healthcare worker (OR, 1.82 [95% CI, 1.37–2.42]), having a child with a chronic medical condition (OR, 1.62 [95% CI, 1.22–2.14]), and experience with more severe COVID-19 (OR, 1.46 [95% CI, 1.14–1.86]) were associated with MIS-C awareness. Respondents with a child aged 12–17 years were less likely to be aware of MIS-C compared to those without (OR, 0.78 [95% CI, .63–.96]), as were male respondents (OR, 0.56 [95% CI, .46–.69]) and respondents aged 18–34 years (OR, 0.72 [95% CI, .54–.94]) compared to those aged 35–44 years. Awareness of MIS-C was associated with higher perceived COVID-19 severity and susceptibility (regression coefficients, 0.18 [95% CI, .10–.25], P < .001; 0.19 [95% CI, .11–.28], P < .001, respectively).
Conclusions
This survey highlights the need to increase parental awareness of MIS-C. Future studies should explore how education regarding MIS-C as a complication of SARS-CoV-2 infection could improve understanding of pediatric disease severity and susceptibility.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Liang, Yuanyuan 2 ; Hendrich, Megan A 3 ; Das, Dhiman 3 ; Petrin, Robert 3 ; Campbell, James D 2
; Sean O’Leary 1 ; Cataldi, Jessica R 1
1 Section of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine , Aurora, Colorado , USA
2 Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland , USA
3 Ipsos US Public Affairs , Washington, District of Columbia , USA





